UbiA prenyltransferase domain-containing protein 1 (UBIAD1) variant c.695 A > G identified in a multigenerational Japanese family with Schnyder corneal dystrophy.

Genetic analysis Pathogenic variation Schnyder corneal dystrophy UBIAD1 UbiA prenyltransferase domain-containing protein 1

Journal

Japanese journal of ophthalmology
ISSN: 1613-2246
Titre abrégé: Jpn J Ophthalmol
Pays: Japan
ID NLM: 0044652

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 13 05 2022
accepted: 25 08 2022
pubmed: 12 11 2022
medline: 28 1 2023
entrez: 11 11 2022
Statut: ppublish

Résumé

We aimed to identify pathogenic variations in the UbiA prenyltransferase domain-containing protein 1 (UBIAD1) gene in a Japanese family with Schnyder corneal dystrophy (SCD). Clinical study METHODS: Three clinically diagnosed SCD patients from a single pedigree participated. Patients 1 and 2 were 69- and 65-year-old sisters, and patient 3 was the 42-year-old daughter of patient 1. Blood samples from the patients were obtained for genetic analysis. Mutation screening of the two UBIAD1 exons was performed using polymerase chain reaction (PCR)-based DNA sequencing. All participants were found to be heterozygous for the pathogenic missense variation c.695 A > G (p.Asn232Ser) in exon 2 of UBIAD1. This is the first report on the pathogenic UBIAD1 variation c.695 A > G (p.Asn232Ser) in a Japanese population. SCD is a rare corneal dystrophy, and further research on additional cases will aid in the elucidation of disease mechanisms and development of therapeutic strategies.

Identifiants

pubmed: 36367598
doi: 10.1007/s10384-022-00951-y
pii: 10.1007/s10384-022-00951-y
doi:

Substances chimiques

Dimethylallyltranstransferase EC 2.5.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-42

Informations de copyright

© 2022. Japanese Ophthalmological Society.

Références

Weiss JS, Møller HU, Aldave AJ, Seitz B, Bredrup C, Kivelä T, et al. IC3D classification of corneal dystrophies—edition 2. Cornea. 2015;34:117–59. Erratum in: Cornea. 2015;34:e32.
Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, White PS, Winters RS, et al. Mutations in the UBIAD1 gene on chromosome short arm 1, region 36, cause Schnyder crystalline corneal dystrophy. Invest Ophthalmol Vis Sci. 2007;48:5007–12.
doi: 10.1167/iovs.07-0845
Evans CJ, Dudakova L, Skalicka P, Mahelkova G, Horinek A, Hardcastle AJ, et al. Schnyder corneal dystrophy and associated phenotypes caused by novel and recurrent mutations in the UBIAD1 gene. BMC Ophthalmol. 2018;18:250.
doi: 10.1186/s12886-018-0918-8
Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, Yu FS, et al. UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS ONE. 2010;5:e10760.
doi: 10.1371/journal.pone.0010760
Kobayashi A, Fujiki K, Murakami A, Sugiyama K. In vivo laser confocal microscopy findings and mutational analysis for Schnyder’s crystalline corneal dystrophy. Ophthalmology. 2009;116:1029–37.e1.
doi: 10.1016/j.ophtha.2008.12.042
Nickerson ML, Bosley AD, Weiss JS, Kostiha BN, Hirota Y, Brandt W,et al. The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum Mutat. 2013;34:317–29.
doi: 10.1002/humu.22230
Orr A, Dubé MP, Marcadier J, Jiang H, Federico A, George S, et al. Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy. PLoS ONE. 2007;2:e685.
doi: 10.1371/journal.pone.0000685
McCarthy M, Innis S, Dubord P, White V. Panstromal Schnyder corneal dystrophy. A clinical pathologic report with quantitative analysis of corneal lipid composition. Ophthalmology. 1994;101:895–901.
doi: 10.1016/S0161-6420(94)31241-3
Nowinska AK, Wylegala E, Teper S, Lyssek-Boron A, Aragona P, Roszkowska AM, et al. Phenotype-genotype correlation in patients with Schnyder corneal dystrophy. Cornea. 2014;33:497–503.
doi: 10.1097/ICO.0000000000000090
Jiang SY, Tang JJ, Xiao X, Qi W, Wu S, Jiang C, et al. Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase. PLOS Genet. 2019;15:e1008289.
doi: 10.1371/journal.pgen.1008289
Jun DJ, Schumacher MM, Hwang S, Kinch LN, Grishin NV, DeBose-Boyd RA. Schnyder corneal dystrophy-associated UBIAD1 is defective in MK-4 synthesis and resists autophagy-mediated degradation. J Lipid Res. 2020;61:746–57.
doi: 10.1194/jlr.RA119000551
Li W. Bringing bioactive compounds into membranes: The UbiA superfamily of intramembrane aromatic Prenyltransferases. Trends Biochem Sci. 2016;41:356–70.
doi: 10.1016/j.tibs.2016.01.007
Weiss JS. Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:616 – 48.
Mehta JS, Vithana EN, Venkataraman D, Venkatraman A, Yong VH, Aung T, et al. Surgical management and genetic analysis of a Chinese family with the S171P mutation in the UBIAD1 gene, the gene for Schnyder corneal dystrophy. Br J Ophthalmol. 2009 Jul;93:926–31.
doi: 10.1136/bjo.2008.152140

Auteurs

Miki Tsuneya (M)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Lily Wei Chen (LW)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Takashi Ono (T)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Yumi Hashimoto (Y)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Kohdai Kitamoto (K)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Yukako Taketani (Y)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Tetsuya Toyono (T)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Makoto Aihara (M)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan.

Takashi Miyai (T)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, #113-8655, Tokyo, Japan. tmiy-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH